Good news from the covid-19 vaccine front as Oxford vaccine shows 70% efficacy
New Delhi, Nov. 23 -- Oxford University AstraZeneca vaccine candidate, AZD1222, against coronavirus disease (Covid-19) has shown 70% efficacy on average, according to the newly published data of phase 2/3 clinical trials held in UK and Brazil, the company announced on Monday.
In effect, the results mean that of all the people who get vaccinated, as high as 70% will not get the disease.
Also, experts had tried two different dosing regimens, of which one showed a better profile of close to 90% efficacy.
"Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.